Physician

Geoffrey Nnamdi Alilonu, M.D.

According to 2025 Medicare claims, Geoffrey Alilonu, M.D. (NPI: 1144295221) practices nephrology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is WEST ALABAMA NEPHROLOGY, PC (NPI: 1225197197) and primary practice location at 35473-5204. Alilonu is affiliated with the Aledade A3047 MS MSSP Enhanced (ACO ID: A3047), participating under the MSSP model.

Alilonu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 527 traditional Medicare patients, billed 6,025 HCPCS/CPT codes, and received $321,625 in Medicare payments. The top billing code was 99232 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes). Part D data shows 2,587 prescription claims across 431 beneficiaries totaling $721,348 in drug costs, led by Rayaldee (Calcifediol). 2016 DME data shows 39 claims. Open Payments data shows 79 records totaling $1,358. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $748,771 to $321,625. Similarly, Part D prescription costs have declined steadily, from $915,629 to $721,348. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$430K$859K2015 Medicare payment: $748,771 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $796,037 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $859,198 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $840,142 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $757,887 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $689,910 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $739,855 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $529,166 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $444,858 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $321,625 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1677,874$748,771
20161,1988,456$796,037
20171,47411,236$859,198
20181,69011,895$840,142
20191,56710,843$757,887
20201,3288,624$689,910
20211,11411,134$739,855
20227058,699$529,166
20236147,236$444,858
20245276,025$321,625

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$606K$1.2M2015 Drug cost: $915,629 (USD; Tot_Drug_Cst)2016 Drug cost: $1,031,012 (USD; Tot_Drug_Cst)2017 Drug cost: $1,168,382 (USD; Tot_Drug_Cst)2018 Drug cost: $1,212,937 (USD; Tot_Drug_Cst)2019 Drug cost: $947,087 (USD; Tot_Drug_Cst)2020 Drug cost: $1,040,147 (USD; Tot_Drug_Cst)2021 Drug cost: $856,724 (USD; Tot_Drug_Cst)2022 Drug cost: $882,368 (USD; Tot_Drug_Cst)2023 Drug cost: $840,176 (USD; Tot_Drug_Cst)2024 Drug cost: $721,348 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153554,292$915,629
20164025,165$1,031,012
20174505,663$1,168,382
20184574,834$1,212,937
20194493,815$947,087
20204563,608$1,040,147
20214773,303$856,724
20224613,167$882,368
20234652,814$840,176
20244312,587$721,348

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.8K$5.6K2015 Medicare payment: $5,625 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,628 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R46$5,625
2016N/R39$5,628
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2481,168$54
83970Parathormone (parathyroid hormone) level187305$40
80048Blood test, basic group of blood chemicals (calcium, total)183297$8
85018Blood count, hemoglobin188306$2
85014Red blood cell concentration measurement187305$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RayaldeeCalcifediol2187,050$315,124
FarxigaDapagliflozin Propanediol1325,406$96,190
VelphoroSucroferric Oxyhydroxide271,030$74,637
VeltassaPatiromer Calcium Sorbitex23930$31,755
LokelmaSodium Zirconium Cyclosilicate391,256$29,797

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.79$1,358Fresenius USA Marketing, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Geoffrey Nnamdi Alilonu, M.D.?

Tedicare shows public-source Medicare data for Geoffrey Nnamdi Alilonu, M.D. (NPI 1144295221), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geoffrey Nnamdi Alilonu, M.D. have ACO affiliation data?

Geoffrey Nnamdi Alilonu, M.D. is shown with ACO affiliation data for Aledade A3047 MS MSSP Enhanced (MSSP, ACO ID A3047).

What billing organization is linked to Geoffrey Nnamdi Alilonu, M.D.?

Geoffrey Nnamdi Alilonu, M.D. is linked to WEST ALABAMA NEPHROLOGY, PC (billing NPI 1225197197) in the available physician profile data.

Does Geoffrey Nnamdi Alilonu, M.D. have Open Payments data?

Geoffrey Nnamdi Alilonu, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.